Andrew Skodyn > Blake, Cassels & Graydon LLP > Toronto, Canada > Lawyer Profile

Blake, Cassels & Graydon LLP

Work Department

Litigation & Dispute Resolution


Andrew’s practice is focused on intellectual property and commercial litigation. As an IP litigator, Andrew is best known for his tenacious approach to patent and trademark litigation in the life sciences and information technology areas. His commercial litigation experience spans complex commercial disputes, class actions and product liability defence. Across his diverse litigation practice, Andrew has conducted numerous significant and precedent-setting trials, applications and appeals. He has represented clients in a wide range of industries, from pharmaceuticals and life sciences to information technology, oil and gas, manufacturing, agriculture, banking and professional services. He also has significant experience preparing opinions and advising clients with respect to regulatory issues, intellectual property portfolios and litigation strategy. Andrew has been counsel at all levels of the Ontario and federal courts, including the Supreme Court of Canada, as well as in numerous mediations and arbitrations.


Andrew is a regular speaker on intellectual property and advocacy issues, as well as being an active member of numerous professional organizations in Canada and the U.S., including the Intellectual Property Institute of Canada, the Advocates’ Society, the Canadian Bar Association, Intellectual Property Owners Association and the American Bar Association.

Lawyer Rankings

Canada > Intellectual property

Adept in portfolio management, a wealth of disputes and the IP elements of corporate transactions, Blake, Cassels & Graydon LLP‘s team is led from Toronto by Chris Hunter, Andrew Skodyn and Melanie Baird. Hunter runs a patent and trademark prosecution practice in addition to his brand protection and portfolio activities, whereas Skodyn is a disputes specialist with considerable knowledge of the biotech, technology and life sciences industries. Baird holds the distinction of serving as counsel in Canada’s first ever biologic patent and biosimilar patent case.